No Association between BRCA2 N372H and Breast Cancer Risk

Truncation mutations in the BRCA2 gene cause a substantial increase in risk of breast cancer. However, these mutations are rare in the general population and account for little of the overall incidence of sporadic breast cancer. Recently, an intronic single-nucleotide polymorphism (G/A at bp 30,763,

[1]  D. Altshuler,et al.  Common variation in BRCA2 and breast cancer risk: a haplotype-based analysis in the Multiethnic Cohort. , 2004, Human molecular genetics.

[2]  G. Colditz,et al.  A functional polymorphism in the progesterone receptor gene is associated with an increase in breast cancer risk. , 2003, Cancer research.

[3]  G. Giles,et al.  The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[4]  J. Chang-Claude,et al.  A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability , 2000, Nature Genetics.